Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Steven Peter St

Affiliations

  • President And Ceo at Aratana Therapeutics Inc. (PETX), 2018-12-17
  • Director at Pharmathene Inc (PIP), 2017-01-05
  • Other at Verastem Inc. (VSTM), 2012-02-03
  • Large Shareholder at Radius Health Inc. (NONE), 2011-12-16
  • Large Shareholder at Pacira Pharmaceuticals Inc. (PCRX), 2011-11-22
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PIP $1.65 25,000 Director 25,000 2015-03-19 Filing
PETX $6.00 8,333 Officer, Director 529,191 2013-07-02 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PETX $5.85 46,094 Officer, Director 516,626 2018-12-17 Filing
PETX $5.86 11,513 Officer, Director 562,720 2018-10-30 Filing
PETX $6.06 75,000 Officer, Director 574,233 2018-09-21 Filing
PETX $4.33 11,513 Officer, Director 649,233 2018-07-30 Filing
PETX $5.00 11,513 Officer, Director 660,746 2018-04-30 Filing